Imugene Limited (ASX:IMU) Receives $11.7m R&D Tax Refund
Imugene Limited (ASX:IMU) announces the receipt of an A$11.7m R&D tax refund to support its clinical development pipeline.
Category: Healthcare
Challenger Gold Limited (ASX: CEL) Completes Strategic Placement and Toll Processing Agreement
Challenger Gold Limited completes a $6.6M placement and secures a toll processing agreement ensuring operational checks for Hualilan project.
Arovella Therapeutics Limited (ASX:ALA) Secures $20M Placement
Arovella Therapeutics (ASX:ALA) announces a $20 million placement to fund Phase 1 clinical trials and solid tumour pipeline expansion.
Radiopharm Theranostics Limited (ASX:RAD) Raises A$8 Million
Radiopharm raises A$8 million from Lantheus, increasing its shareholding to 12.16% to support the clinical pipeline.
AdAlta Limited (ASX:1AD) to Present at Biotech Showcase 2025
AdAlta Limited (ASX:1AD) to present its advancements in cell therapeutics at Biotech Showcase 2025 during JPMorgan Healthcare Week.
NTAW Holdings Limited (ASX:NTD) Faces Termination of Dunlop Distribution Agreements
NTAW Holdings Limited (ASX:NTD) received termination notices for its Dunlop distribution agreements due to Goodyear’s brand sale to SRI.
Amaero International Limited (ASX:3DA) Secures A$38 Million Loan
Amaero International Limited secures A$38 million loan from EXIM to enhance U.S. manufacturing capabilities and create skilled jobs.
St George Mining Limited (ASX:SGQ) Initiates Niobium Project Collaboration
St George Mining commences a program to enhance processing for niobium and rare earths at its Araxá Project in Brazil.
Augustus Minerals (ASX:AUG) Announces VTEM Survey Results at Ti Tree
Augustus Minerals announces significant findings from the VTEM survey at the Ti Tree Project, revealing key targets for further mineral exploration.
OncoSil Medical Limited (ASX:OSL) Secures $1.05 Million R&D Tax Incentive
OncoSil Medical secures a $1.05 million R&D tax incentive to support advancements in its pancreatic cancer treatment technology.